Simultaneous multianalyte ELISA performed on a microarray platform

Clinical Chemistry

Volumn 47, Issue 8, 2001, Pages 1451-1457

  Wiese, R ^a   Belosludtsev, Y ^a   Powdrill, T ^a   Thompson, P ^a   Hogan, M ^a  

^a Genometrix Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; INTERLEUKIN 6; PROSTATE SPECIFIC ANTIGEN;

ANALYTIC METHOD; ARTICLE; CALIBRATION; ENZYME LINKED IMMUNOSORBENT ASSAY; LABORATORY TEST; PROTEIN TARGETING;

EID: 0034915925     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.8.1451     Document Type: Article

References (19)

1. Microarrays and macroconsequences
2. Array of hope
3. Molecular interactions on microarrays
4. High-throughput microarray-based enzyme-linked immunosorbent assay (ELISA)
5. Ligand assays: From electrophoresis to miniaturized microarrays
6. Multianalyte microspot immunoassay-microanalytical "compact disk" of the future
7. Microarrays: Their origins and applications
8. Profiling of amyloid β peptide variants using SELDI proteinchip arrays
9. Protein microarrays for gene expression and antibody screening
10. Mass-sensing, multianalyte microarray immunoassay with imaging detection
11. Multianalyte immunoassay based on spatially distinct fluorescent areas quantified by laser-excited solid-phase time-resolved fluorometry
12. Simultaneous quadruple-label fluorometric immunoassay of thyroid-stimulating hormone, 17 α-hydroxyprogesterone, immunoreactive trypsin and creatine kinase MM isoenzyme in dried blood spots
13. Preliminary examination of time-resolved fluorometry for protein array applications
14. Streptavidinpolyvinylamine conjugates labeled with a europium chelate: Applications in immunoassay, immunohistochemistry and microarrays
15. Elevated levels of circulating interleukin-6 and transforming growth factor-β1 in patients with metastatic prostatic carcinoma
16. Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: Which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer
17. Molecular forms of prostate-specific antigen in malignant and benign prostatic tissue: Biochemical and diagnostic implications
18. Improved discrimination of prostate cancer and benign prostatic hyperplasia by means of the quotient of free and total PSA
19. New use of cyanosilane coupling agent for direct binding of antibodies to silica supports. Physicochemical characterization of molecularly bioengineered layers